Adlai Nortye Group Ltd. announced it will present new data on its investigational cancer drug AN4035 at the 38th EORTC-NCI-AACR Symposium in Barcelona on November 19, 2026. AN4035 is a novel antibody-drug conjugate targeting CEACAM5 with a pan-RAS(ON) inhibitor payload, designed to improve treatment selectivity and effectiveness. The presentation will cover translational and combination data, including its use with EGFR blockade, supporting ongoing Phase I trials in multiple countries. This highlights progress in developing innovative therapies for RAS-addicted solid tumors and potential new cancer treatment options.
Adlai Nortye's AN4035 program update is the subject, with this snapshot of the Health sector on Pluang as of Oct 28, 2026 03:11 WIB: Out of 150 priced US Health stocks, 88 rose and 62 fell. Notably, SLS rose 7.14% to USD 12.15 with a typical hold time of 6 days, contrasting with TXG's 6.98% rise to USD 78.05 despite 82% sell order activity and a much longer typical hold time of 92 days. CLPT also gained 6.97% to USD 9.67, supported by 100% buy orders and a typical hold time of 11 days.
Vallourec will publish its Q3 2026 financial results on November 20, 2026, at 07:30 AM CET. The company's CEO Philippe Guillemot and CFO Nathalie Delbreuve will present the results via a conference call and webcast at 09:30 AM CET the same day. Inves...
MyPropCapital Technology Limited has launched a new trading evaluation platform that uses the Arbitrum One blockchain to record all fees, rules, passes, and rewards publicly. This system allows traders to verify every detail of their trading deals wi...
The European Central Bank (ECB) has confirmed KBC Group's minimum capital requirements for 2026 following its Supervisory Review and Evaluation Process (SREP). KBC must maintain a fully loaded CET1 ratio of 10.94%, which includes various regulatory b...
Bitget Wallet introduced Virtual Account, allowing users to open free USD and EUR accounts within their self-custodial crypto wallet, powered by licensed partner Noah. Funds deposited convert automatically to stablecoins like USDT or USDC, usable for...
The European Central Bank (ECB) has confirmed KBC Group's minimum capital requirements for 2026, maintaining the Pillar 2 Requirement at 1.95% and Pillar 2 Guidance at 1.00%. This results in an overall CET1 capital requirement of 10.94%. As of Q2 202...
